University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA) : results from BSRBR-AS

Simple item page
dc.contributor.authorMacfarlane, Gary J.
dc.contributor.authorPathan, Ejaz
dc.contributor.authorJones, Gareth T.
dc.contributor.authorDean, Linda E.
dc.contributor.institutionUniversity of Aberdeen.Vice Principalsen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.date.accessioned2020-09-21T10:06:00Z
dc.date.available2020-09-21T10:06:00Z
dc.date.issued2020-09
dc.descriptionWe are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. We are grateful to Jonathan Lock for commenting on the manuscript. Funding: This work was supported by the British Society for Rheumatology (BSR) who have funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input in to the topics for analysis in the register nor the work involved in undertaking analysis. Analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work [grant number 20665].en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent279939
dc.identifier152264771
dc.identifier5c3414b1-6f89-457d-95df-f1727134e843
dc.identifier31990352
dc.identifier85089454892
dc.identifier000574394600046
dc.identifier.citationMacfarlane, G J, Pathan, E, Jones, G T & Dean, L E 2020, 'Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA) : results from BSRBR-AS', Rheumatology, vol. 59, no. 9, pp. 2481-2490. https://doi.org/10.1093/rheumatology/kez657en
dc.identifier.doi10.1093/rheumatology/kez657
dc.identifier.iss9en
dc.identifier.issn1462-0324
dc.identifier.otherORCID: /0000-0003-2322-3314/work/75816019
dc.identifier.otherORCID: /0000-0003-0016-7591/work/83703974
dc.identifier.urihttps://hdl.handle.net/2164/15150
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85089454892&partnerID=8YFLogxKen
dc.identifier.vol59en
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectaxial spondyloarthritisen
dc.subjectankylosing spondylitisen
dc.subjectresponseen
dc.subjecttreatmenten
dc.subjectanti-TNF-alphaen
dc.subjectbiologic therapyen
dc.subjectDEPRESSIONen
dc.subjectSHORT-TERM IMPROVEMENTen
dc.subjectWORK PRODUCTIVITYen
dc.subjectRELIABILITYen
dc.subjectANKYLOSING-SPONDYLITISen
dc.subjectBATHen
dc.subjectFIBROMYALGIAen
dc.subjectINHIBITORSen
dc.subjectACTIVITY SCORE ASDASen
dc.subjectBRITISH SOCIETYen
dc.subjectR Medicine (General)en
dc.subjectPharmacology (medical)en
dc.subjectRheumatologyen
dc.subjectMedical Research Council (MRC)en
dc.subject20665en
dc.subjectOtheren
dc.subjectVersus Arthritisen
dc.subject.lccR1en
dc.titlePredicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA) : results from BSRBR-ASen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Macfarlane_etal_Rheum_Predicting_response_VOR.pdf
Size:
273.38 KB
Format:
Adobe Portable Document Format
Download

Collections

All research